Abstract

Ample evidence indicates that obesity causes dysfunctions in the lung. Previous studies also show that cholinergic anti-inflammatory pathways play crucial roles in obesity-induced chronic inflammation via α7 nicotinic acetylcholine receptor (α7nAChR) signaling. However, it remains unclear whether and how obesity affects the expressions of α7nAChR in myeloid cells in the lung. To address this question, we treated regular chow diet-fed mice or high-fat diet induced obese mice with lipopolysaccharide (LPS) or vehicle via endotracheal injections. By using a multicolor flow cytometry approach to analyze and characterize differential cell subpopulations and α7nAChR expressions, we find no detectable α7nAChR in granulocytes, monocytes and alveolar macrophages, and low expression levels of α7nAChR were detected in interstitial macrophages. Interestingly, we find that a challenge with LPS treatment significantly increased expression levels of α7nAChR in monocytes, alveolar and interstitial macrophages. Meanwhile, we observed that the expression levels of α7nAChR in alveolar and interstitial macrophages in high-fat diet induced obese mice were lower than regular chow diet-fed mice challenged by the LPS. Together, our findings indicate that obesity alters the expressions of α7nAChR in differential lung myeloid cells.

Highlights

  • Ample evidence indicates that obesity causes dysfunctions in the lung

  • Glucose tolerance tests (GTTs) were subsequently performed, and we observed that the blood glucose levels of HFD group mice were higher than that of RCD group mice at 30, 60, 90 and 120 min post intraperitoneal (i.p.) injections of glucose (Fig. 1b), indicating metabolic phenotypes of diet-induced obesity

  • The interactions of lipid metabolism and macrophages have been investigated in previous s­ tudies[38]

Read more

Summary

Introduction

Previous studies show that cholinergic anti-inflammatory pathways play crucial roles in obesity-induced chronic inflammation via α7 nicotinic acetylcholine receptor (α7nAChR) signaling. It remains unclear whether and how obesity affects the expressions of α7nAChR in myeloid cells in the lung. We find that a challenge with LPS treatment significantly increased expression levels of α7nAChR in monocytes, alveolar and interstitial macrophages. We observed that the expression levels of α7nAChR in alveolar and interstitial macrophages in high-fat diet induced obese mice were lower than regular chow dietfed mice challenged by the LPS. Lipopolysaccharide (LPS) treatment induces changes in inflammatory-related gene expressions, and approximately half of the genes induced by LPS-stimulated lung inflammation were specific in DIO m­ ice[15]. The mechanism by which the α7nAChR regulates obesity-induced lung inflammation remains unclear

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call